NCT02426047View on ClinicalTrials.gov

Medium Chain Triglycerides as an Adjunct to the Modified Atkins Diet for Women With Catamenial Epilepsy

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2020

Conditions
EpilepsySeizureCatamenial EpilepsyMedically Resistant EpilepsyMedically Resistant Seizures
Interventions
DIETARY_SUPPLEMENT

betaquik®

Participants will add betaquik® (a liquid emulsion of medium chain triglycerides) for a 10 day time interval starting 2 days prior to and encompassing the primary catamenial pattern.

Trial Locations (2)

21287

Johns Hopkins Hospital, Baltimore

53792

University of Wisconsin Hospital & Clinics, Madison

All Listed Sponsors
collaborator

Vitaflo International, Ltd

INDUSTRY

lead

Johns Hopkins University

OTHER

NCT02426047 - Medium Chain Triglycerides as an Adjunct to the Modified Atkins Diet for Women With Catamenial Epilepsy | Biotech Hunter | Biotech Hunter